Dian Diagnostics Group Co.,Ltd. (SHE:300244)
China · Delayed Price · Currency is CNY 18.96
+0.01 (0.05%)
Apr 28, 2026, 3:13 PM CST
Dian Diagnostics Group Revenue
In the year 2025, Dian Diagnostics Group had annual revenue of 10.10B CNY, down -17.22%. Dian Diagnostics Group had revenue of 2.53B in the quarter ending December 31, 2025, a decrease of -13.88%.
Revenue
10.10B
Revenue Growth
-17.22%
P/S Ratio
1.15
Revenue / Employee
1.15M
Employees
8,773
Market Cap
11.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.10B | -2.10B | -17.22% |
| Dec 31, 2024 | 12.20B | -1.21B | -9.04% |
| Dec 31, 2023 | 13.41B | -6.87B | -33.89% |
| Jan 1, 2023 | 20.28B | 7.20B | 55.03% |
| Jan 1, 2022 | 13.08B | 2.43B | 22.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Runda Medical Technology | 7.40B |
| Guangzhou Kingmed Diagnostics Group | 5.91B |
| BGI Genomics | 3.84B |
| Maccura Biotechnology Co.Ltd | 2.21B |
| Joinn Laboratories(China)Co.,Ltd. | 1.66B |
| Beijing Strong Biotechnologies,Inc. | 1.37B |
| Thalys Medical Technology Group | 1.25B |
| Amoy Diagnostics | 1.20B |